THERAPEUTIC POTENTIAL OF H4R AGONISTS IN AN EXPERIMENTAL MODEL OF HUMAN BREAST CANCER

被引：0
|
作者：
Martinel Lamas, D. [1 ]
Croci, M. [1 ]
Sambuco, L. [1 ]
Carabajal, E. [1 ]
Massari, N. [1 ]
Bergoc, R. M. [1 ]
Rivera, E. S. [1 ]
Medina, V. A. [1 ]
机构：
[1] Univ Buenos Aires, Fac Farm & Bioquim, Lab Radioisotopos, RA-1113 Buenos Aires, DF, Argentina
来源：
INFLAMMATION RESEARCH | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [31] AN H4R ANTAGONIST, JNJ-39758979, IS EFFICACIOUS IN CLINICAL STUDIES OF EXPERIMENTAL ITCH AND ON ITCH IN ATOPIC DERMATITIS
    Thurmond, Robin
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (05) : 622 - 622
  • [32] THE HISTAMINE H4-RECEPTOR (H4R) AFFECTS EXPERIMENTAL COLITIS DUE TO ITS FUNCTIONAL EXPRESSION ON EPITHELIAL CELLS OF THE MOUSE COLON
    Neumann, D.
    INFLAMMATION RESEARCH, 2018, 67 : S17 - S18
  • [33] Histamine H4 Receptor (H4R) Is Expressed By Both Osteoarthritic (OA) And Rheumatoid Arthritis (RA) Human Tissues.
    Manacu, C.
    Dion, M.
    Attalah, L. H.
    Renous, R.
    Frohn, M.
    Ng, G. Y.
    Moldovan, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S280 - S280
  • [34] Effects of a Selective Histamine H4R Antagonist on Inflammation in a Model of Carrageenan-Induced Pleurisy in the Rat
    Pini, A.
    Somma, T.
    Formicola, G.
    Lucarini, L.
    Bani, D.
    Thurmond, R.
    Masini, E.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (09) : 1338 - 1344
  • [35] ROLE OF HISTAMINE H4R IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    Pini, A.
    Bani, D.
    Passani, M. B.
    Thurmond, R. L.
    Stark, H.
    Masini, E.
    INFLAMMATION RESEARCH, 2012, 61 : S48 - S48
  • [36] THE LONG AND WINDING ROAD-CLINICAL DEVELOPMENT OF H4R ANTAGONISTS
    Thurmond, R. L.
    INFLAMMATION RESEARCH, 2017, 66 : S48 - S48
  • [37] HISTAMINE H4 RECEPTOR AGONISTS ARE SYNERGISTIC WITH DOXORUBICIN IN BREAST CANCER
    Martinel Lamas, D.
    Cortina, E.
    Carabajal, E.
    Perazzo, J. C.
    Rivera, E. S.
    Medina, V. A.
    INFLAMMATION RESEARCH, 2014, 63 : S24 - S24
  • [38] HETEROCYCLIC MUSCARINIC AGONISTS AS EXPERIMENTAL TOOLS AND POTENTIAL THERAPEUTIC AGENTS
    HANSEN, AB
    FALCH, E
    JORGENSEN, FS
    KROGSGAARDLARSEN, P
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, : 112 - 112
  • [39] The dual H3/4R antagonist thioperamide does not fully mimic the effects of the ‘standard’ H4R antagonist JNJ 7777120 in experimental murine asthma
    Detlef Neumann
    Silke Beermann
    Heike Burhenne
    Silke Glage
    Christina Hartwig
    Roland Seifert
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 983 - 990
  • [40] The dual H3/4R antagonist thioperamide does not fully mimic the effects of the 'standard' H4R antagonist JNJ 7777120 in experimental murine asthma
    Neumann, Detlef
    Beermann, Silke
    Burhenne, Heike
    Glage, Silke
    Hartwig, Christina
    Seifert, Roland
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (11) : 983 - 990
12345